Nicholas A. Meanwell

Statistics

Publications

186

Citations

14.6K

H-Index

Active since

1980

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (India)

Biocon (India)

Nicholas A. Meanwell is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicinal chemistry, and antiviral pharmacology.

ORCID

Publications per year

1980–2023

186

Publications

186

Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design

Nicholas A. Meanwell · Journal of Medicinal Chemistry · 2011 · 2.8K citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Min Gao, Richard E. Nettles, Makonen Belema et al. · Nature · 2010 · 937 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design

Brett R. Beno, Kap‐Sun Yeung, Michael D. Bartberger et al. · Journal of Medicinal Chemistry · 2015 · 766 citations

Natural Sciences, Chemistry, Medicinal Chemistry +16

Metabolic and Pharmaceutical Aspects of Fluorinated Compounds

Benjamin M. Johnson, Yue‐Zhong Shu, Xiaoliang Zhuo et al. · Journal of Medicinal Chemistry · 2020 · 679 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +15

A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding

Pin‐Fang Lin, Wade Blair, Tao Wang et al. · Proceedings of the National Academy of Sciences · 2003 · 360 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

1–5 of 186